MICHAEL RAAB
CIK 1321402 · President & CEO · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.11M
Companies
4
Total Filings
120
Lifetime Open-Market Net
-$8.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARDX | President & CEO | 1,776,351 | $5.69 | $10.11M | -$8.12M | 83 | 2026-05-22 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 0 | $14.49 | $0 | -$629.0K | 28 | 2026-04-27 |
| TPST | Director | — | $1.26 | — | $0 | 6 | 2026-01-28 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Director | — | — | — | $0 | 3 | 2008-03-31 |
Recent Filings · Page 5 of 12
120 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-01 | ARDX | Mixed | — | -$162.4K | EDGAR |
| 2024-04-17 | ARDX | Sell (S) | −7,500 | -$52.9K | EDGAR |
| 2024-04-02 | ARDX | Sell (S) | −1,518 | -$11.1K | EDGAR |
| 2024-03-06 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Exer (M) | +15,000 | $42.0K | EDGAR |
| 2024-02-22 | ARDX | Sell (S) | −22,917 | -$200.4K | EDGAR |
| 2024-01-18 | ARDX | Grant (A) | +475,000 | $0 | EDGAR |
| 2023-11-22 | ARDX | Sell (S) | −11,368 | -$49.6K | EDGAR |
| 2023-08-23 | ARDX | Sell (S) | −11,419 | -$40.6K | EDGAR |
| 2023-06-20 | TPST | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +8,584 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.